Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Promising phase II data presented for Novastan in acute MI

March 21, 1997

Fujisawa presents selective, nonpeptide thrombin receptor inhibitor

March 21, 1997

Fujisawa selects orally active fibrinogen antagonist for clinical studies

March 20, 1997

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Mitsui Toatsu reveals orally active antiplatelet agent

March 20, 1997

InTIME trial indicates nPA superior to tPA in MI

March 19, 1997

Aggrastat prevents heart attack, death and other complications in unstable angina

March 19, 1997

PGI2 agonists described by Fujisawa

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

New clot buster comparable to t-PA in AMI

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...